货号:A521632
同义名:
四氧嘧啶水合物
/ Alloxan hydrate; Alloxan (hydrate)
Alloxan Monohydrate广泛用于实验室中用于诱导实验性糖尿病模型。其主要生物活性是通过特异性破坏胰腺β细胞,引发氧化应激和细胞凋亡,导致胰岛素缺乏。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| Administration | Dosage | Frequency | Description | References | ||
| WBN/Kob rats | Diabetic model | Tail vein injection | 50 mg/kg for males, 40 mg/kg for females | Single dose, observed for 50 or 75 weeks | Induction of squamous cell carcinoma, acceleration of diabetic symptoms | Cancer Sci. 2006 Oct;97(10):1023-30 |
| Syrian hamsters | Pancreatic cancer model | Intravenous injection | 60 mg/kg | Single dose, experiment lasted 46 weeks | To study the inhibitory effect of Alloxan on BOP-induced pancreatic cancer. Results showed that Alloxan administered 2 hours before BOP significantly inhibited pancreatic carcinogenesis (P<0.01). | Am J Pathol. 1983 Mar;110(3):310-4 |
| C57BL/6J male mice | Diabetic model | Tail vein injection | 65 mg/kg | Single injection, observed for 10 weeks | To induce diabetes and observe its effects on cardiac function, results showed increased LV tissue Hcy levels and impaired diastolic function in diabetic mice. | Int J Biol Sci. 2008 Aug 6;4(4):236-44 |
| Swine | Alloxan-induced diabetes model | Intravenous injection | 150 mg/kg | Single injection, observed for 0 to 90 days | To study the effect of Alloxan-induced diabetes on Müller cell contraction-promoting activity in swine vitreous, showing significant increases in activity in diabetic swine vitreous | Invest Ophthalmol Vis Sci. 2011 Sep 27;52(10):7485-91 |
| New Zealand white rabbits | Alloxan-induced diabetic rabbit ear ulcer model | Ear vein injection | 150 mg/kg | Single injection, observed until the end of the experiment | To induce a diabetic state and evaluate its effect on wound healing, results showed significantly delayed wound healing in diabetic rabbits. | Stem Cell Res Ther. 2013;4(6):158 |
| Wistar rats | Alloxan-induced diabetic rat model | Intraperitoneal injection | 50 mg/kg | Single injection | Induction of diabetes model, blood glucose levels significantly increased (21.83–27.01 mmol/L) after 72 hours. | Mar Drugs. 2015 May 15;13(5):3072-90 |
| Wistar rats | Diabetic model | Intraperitoneal injection | 50 mg/kg | Single injection | Induce diabetic model, significantly increase blood glucose levels | Mar Drugs. 2015 May 15;13(5):3072-90 |
| Wistar rats | Alloxan-induced diabetic model | Intraperitoneal injection | 150 mg/kg | Single injection, lasting four weeks | To investigate the ameliorative effects of probiotic and vitamin C on hyperglycemia, oxidative stress, and dyslipidemia in alloxan-induced diabetic rats. Results showed that the combination of probiotic and vitamin C significantly reduced blood glucose levels, decreased malondialdehyde concentrations in serum, brain, and kidneys, and increased the activity of antioxidant enzymes. | Nutrients. 2016 May 5;8(5):151 |
| Wistar rats | Diabetic model | Intraperitoneal injection | 150 mg/kg | Single injection, duration four weeks | Induce diabetes and study the ameliorative effects of probiotic and vitamin C on hyperglycaemia, oxidative stress and dyslipidaemia | Nutrients. 2016 May 5;8(5):151 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
6.25mL 1.25mL 0.62mL |
31.23mL 6.25mL 3.12mL |
62.46mL 12.49mL 6.25mL |
|
| CAS号 | 2244-11-3 |
| 分子式 | C4H4N2O5 |
| 分子量 | 160.09 |
| SMILES Code | O=C1NC(C(C(N1)=O)=O)=O.[H]O[H] |
| MDL No. | MFCD00149399 |
| 别名 | 四氧嘧啶水合物 ;Alloxan hydrate; Alloxan (hydrate) |
| 运输 | 蓝冰 |
| InChI Key | DSXMTJRUNLATRP-UHFFFAOYSA-N |
| Pubchem ID | 16723 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(655.9 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 100 mg/mL(624.67 mM) 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1